Analysis of treatment practices for elderly cancer patients in Ontario, Canada

Journal of Clinical Oncology

Volumn 23, Issue 16, 2005, Pages 3802-3810

  Townsley, Carol ^a   Pond, Gregory R ^a   Peloza, Brenda ^a   Kok, Joanne ^a   Naidoo, Kendra ^a   Dale, Darlene ^a   Herbert, Carole ^a   Holowaty, Eric ^a   Straus, Sharon ^a   Siu, Lillian L ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BREAST CANCER; CANADA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL PRACTICE; COLORECTAL CANCER; COMORBIDITY; CONTROLLED STUDY; ELDERLY CARE; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION; AGE DISTRIBUTION; ARTICLE; BREAST TUMOR; CLINICAL TRIAL; COLORECTAL TUMOR; CONTROLLED CLINICAL TRIAL; LUNG TUMOR; MEDICAL RECORD; MORTALITY; RANDOMIZED CONTROLLED TRIAL; REGISTER; RETROSPECTIVE STUDY;

AGE DISTRIBUTION; AGED; BREAST NEOPLASMS; CANADA; COLORECTAL NEOPLASMS; HUMANS; LUNG NEOPLASMS; MEDICAL RECORDS; ONTARIO; PHYSICIAN'S PRACTICE PATTERNS; REGISTRIES; RETROSPECTIVE STUDIES;

EID: 20544432751     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.06.742     Document Type: Review

References (43)

1. Yancik R: Cancer burden in the aged: An epidemiologic and demographic overview. Cancer 80:1273-1283, 1997
2. Yancik R, Havlik RJ, Wesley MN, et al: Cancer and comorbidity in older patients: A descriptive profile. Ann Epidemiol 5:399-412, 1996
3. Hamerman D: Toward an understanding of frailty. Ann Intern Med 130:945-950, 1999
4. Balducci L: Geriatric oncology. Crit Rev Oncol Hematol 46:211-220, 2003
5. Terret C: Management and geriatric assessment of cancer in the elderly. Expert Rev Anticancer Ther 4:469-475, 2004
6. Food and Drug Administration: Guideline for the study of drugs likely to be used in the elderly. http://www.fda.gov/cder/guidance/old040fn.pdf
7. Lewis JH, Kilgore ML, Goldman DP, et al: Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol 21:1383-1389, 2003
8. Yee KWL, Pater JL, Pho L, et al: Enrollment of older patients in cancer treatment trials in Canada: Is age a barrier? J Clin Oncol 21:1618-1623, 2003
9. Sateren WB, Trimble EL, Abrams J, et al: How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol 20:2109-2117, 2002
10. Hutchins LF, Unger JM, Crowley JJ, et al: Underrepresentation of patients 65 years of age or older in cancer treatment trials. N Engl J Med 341:2061-2067, 1999
11. Trimble EL, Carter CL, Cain D, et al: Representation of older patients in cancer treatment trials. Cancer 74:2208-2214, 1994 (suppl 7)
12. Murthy VH, Krumbolz HM, Gross CP: Participation in cancer clinical trials. JAMA 291: 2720-2726, 2004
13. Tyldesley S, Zhang-Salomons J, Groom PA, et al: Association between age and the utilization of radiotherapy in Ontario. Int J Radiat Oncol Biol Phys 47:469-480, 2000
14. Huang J, Zhou S, Groome P, et al: Factors affecting the use of palliative radiotherapy in Ontario. J Clin Oncol 19:137-144, 2001
15. Paszat L, Laperriere N, Groome P, et al: A population-based study of glioblastoma multiforme. Int J Radiat Oncol Biol Phys 51:100-107, 2001
16. Earle CC, Neumann PJ, Gelber RD, et al: Impact of referral patterns on the use of chemotherapy for lung cancer. J Clin Oncol 20:1786-1792, 2002
17. Easson AM, Cotterchio M, Crosby JA, et al: A population-based study of the extent of surgical resection of potentially curable colon cancer. Ann Surg Oncol 9:380-387, 2002
18. Vercelli M, Quaglia A, Casella C, et al: Relative survival in elderly cancer patients in Europe. Eur J Cancer 34:2264-2270, 1998
19. Magagnoli M, Castagna L, Timofeeva I, et al: High-dose chemotherapy supported by peripheral blood stem cell transplantation in elderly versus younger lymphoma patients: A matched analysis. Leuk Lymphoma 44:1439-1440, 2003
20. Jantunen E, Mahlamaki E, Nousiainen T, et al: Feasibility and toxicity of high-dose chemotherapy supported by peripheral blood stem cell transplantation in elderly patients (≥ 60 years) with non-Hodgkin's lymphoma: Comparison with patients < 60 years treated within the same protocol. Bone Marrow Transplant 26:737-741, 2000
21. Tirelli U, Zagnoel V, Serraino D, et al: Non-Hodgkin's lymphomas in 137 patients age 70 and older: A retrospective European Organization for Research and Treatment of Cancer Lymphoma Group Study. J Clin Oncol 6:1708-1713, 1988
22. Silliman RA, Guadagnoli E, Weitberg AB: Age as a predictor of diagnostic and initial treatment intensity in newly diagnosed cancer patients. J Gerontol 44:M46-M50, 1989
23. Gomez H, Mas L, Casanova L, et al: Elderly patients with aggressive non-Hodgkin's lymphoma treated with CHOP chemotherapy plus granulocyte- macrophage colony-stimulating factor: Identification of two age groups with differing hematologic toxicity. J Clin Oncol 16: 2352-2358, 1998
24. Christman K, Muss HB, Case LD, et al: Chemotherapy of metastatic breast cancer in the elderly: The Piedmont Oncology Association experience. JAMA 268:57-62, 1992
25. Sekine I, Yamamoto N, Kunitoh H, et al: Treatment of small cell lung cancer in the elderly based on a critical literature review of clinical trials. Cancer Treat Rev 30:359-368, 2004
26. Ceccaroni M, D'Agostino G, Ferrandina G, et al: Gynecological malignancies in elderly patients: Is age 70 a limit to standard dose chemotherapy? An Italian retrospective and multicentric study. Gynecol Oncol 85:445-450, 2002
27. Goffin JR, Rajan R, Souhami L: Tolerance of radiotherapy and chemotherapy in elderly patients with bladder cancer. Am J Clin Oncol 27:172-177, 2004
28. Giovanazzi-Banon S, Rademaker A, Lai G, et al: Treatment tolerance of elderly cancer patients entered onto phase II clinical trials: An Illinois Cancer Center study. J Clin Oncol 112: 2447-2452, 1994
29. Shepherd FA, Abratt RP, Anderson H, et al: Gemcitabine in the treatment of elderly patients with advanced non-small cell lung cancer. Semin Oncol 24:57-50-57-55, 1997 (suppl 7)
30. Fata F, Mirza A, Craig G, et al: Efficacy and toxicity of adjuvant chemotherapy in elderly patients with colon carcinoma: A 10 year experience of the Geisinger Medical Center. Cancer 94:1931-1938, 2002
31. Townsley CA, Naidoo K, Pond GR, et al: Are older cancer patients being referred to oncologists? A mail questionnaire of Ontario primary care practitioners to evaluate their referral patterns. J Clin Oncol 21:4627-4635, 2003
32. Greene FL, Page DL, Fleming ID, et al: American Joint Committee on Cancer, Staging Manual (ed 6). New York, NY, Springer Verlag Publishing, 2002
33. Statistics Canada: Postal code conversion file, January 1999 edition. http://www.statcan .ca:8096/bsolc/english/bsolc?catno=92F0153G
34. Berghmans T, Tragas G, Sculier JP: Age and treatment of non-small-call lung cancer: A database analysis in elderly patients. Support Care Cancer 10:619-623, 2002
35. Schwartz KL, Alibhai SMH, Tomlinson G, et al: Continued undertreatment of older men with localized prostate cancer. Urology 62:860-865, 2003
36. Alibhai SMH, Krahn MD, Cohen MM, et al: Is there age bias in the treatment of localized prostate carcinoma? Cancer 100:72-81, 2003
37. Tibshirani RJ, Efron B: An Introduction to the Bootstrap. New York, NY: Chapman & Hall, 1993
38. Department of Health and Human Services: HCFA fact sheet: Medicare coverage routine costs of beneficiaries in clinical trials, http:// www.cms.hhs.gov/medlearn/ctfs13.pdf
39. Balducci L: Geriatric oncology: Challenges for the new century. Eur J Cancer 36:1741-1754, 2000
40. Harlacher R, Fusgen I: Geriatric assessment in the elderly cancer patient. J Cancer Res Clin Oncol 126:369-374, 2000
41. Yates J, Chalmer B, McKegney P: Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer 45:2220-2224, 1980
42. Carmen KS, Cohen HJ: Functional status and the elderly cancer patient. Crit Rev Oncol Hematol 43:191-208, 2002
43. Rogatko A, Babb JS, Wang H, et al: Patient characteristics compete with dose as predictors of acute treatment toxicity in early phase clinical trials. Clin Cancer Res 10:4645-4651, 2004